Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.

Owens CD.

J Vasc Surg. 2010 Jul;52(1):205-7. doi: 10.1016/j.jvs.2010.01.097.

PMID:
20434300
[PubMed - indexed for MEDLINE]
Free Article
2.

The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.

Colaizzo D, Amitrano L, Tiscia GL, Scenna G, Grandone E, Guardascione MA, Brancaccio V, Margaglione M.

J Thromb Haemost. 2007 Jan;5(1):55-61. Epub 2006 Oct 20.

PMID:
17059429
[PubMed - indexed for MEDLINE]
3.

Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis.

Yoo EH, Jang JH, Park KJ, Gwak GY, Kim HJ, Kim SH, Kim DK.

Int J Lab Hematol. 2011 Oct;33(5):471-6. doi: 10.1111/j.1751-553X.2011.01308.x. Epub 2011 Mar 24.

PMID:
21435189
[PubMed - indexed for MEDLINE]
4.

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.

De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, Leone G.

J Thromb Haemost. 2007 Apr;5(4):708-14. Epub 2007 Jan 29.

PMID:
17263783
[PubMed - indexed for MEDLINE]
5.

JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms.

Villani L, Bergamaschi G, Primignani M, Rosti V, Carolei A, Poletto V, Catarsi P, Spolverini A, Vannucchi AM, Barosi G.

Leuk Res. 2012 Jan;36(1):e7-9. doi: 10.1016/j.leukres.2011.08.008. Epub 2011 Sep 3. No abstract available.

PMID:
21890200
[PubMed - indexed for MEDLINE]
6.

Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.

Grandone E, Colaizzo D, Tiscia GL, Vergura P, Chinni E, Iannaccone L, Antinolfi I, Guardascione MA, Margaglione M.

Thromb Haemost. 2008 Mar;99(3):640-2. doi: 10.1160/TH07-09-0570. No abstract available.

PMID:
18327418
[PubMed - indexed for MEDLINE]
7.

JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.

Allegra A, Alonci A, Penna G, D'Angelo A, Rizzotti P, Granata A, Musolino C.

Acta Haematol. 2009;121(4):218-20. doi: 10.1159/000221962. Epub 2009 May 29.

PMID:
19478480
[PubMed - indexed for MEDLINE]
8.

JAK2 V617F: implications for thrombosis in myeloproliferative diseases.

Hexner EO.

Curr Opin Hematol. 2007 Sep;14(5):450-4. Review.

PMID:
17934351
[PubMed - indexed for MEDLINE]
9.

JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.

Michiels JJ, Commandeur S, Hoogenboom GJ, Wegman JJ, Scholten L, van Rijssel RH, De Raeve H.

Ann Hematol. 2007 Nov;86(11):793-800. Epub 2007 Aug 9. Review.

PMID:
17687555
[PubMed - indexed for MEDLINE]
10.

Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes.

Karmacharya P, Aryal MR, Donato A.

World J Gastroenterol. 2013 Nov 21;19(43):7813-5. doi: 10.3748/wjg.v19.i43.7813.

PMID:
24282370
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?

Xavier SG, Gadelha T, Rezende SM, Zalcberg IR, Spector N.

Int J Lab Hematol. 2011 Apr;33(2):117-24. doi: 10.1111/j.1751-553X.2010.01275.x. Epub 2010 Dec 1. Review.

PMID:
21118380
[PubMed - indexed for MEDLINE]
12.

[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].

Iványi JL, Marton E, Plander M.

Orv Hetil. 2011 Nov 6;152(45):1795-803. doi: 10.1556/OH.2011.29226. Hungarian.

PMID:
22011365
[PubMed - indexed for MEDLINE]
13.

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.

Fiorini A, Chiusolo P, Rossi E, Za T, De Ritis DG, Ciminello A, Leone G, De Stefano V.

Am J Hematol. 2009 Feb;84(2):126-7. doi: 10.1002/ajh.21335. No abstract available.

PMID:
19105231
[PubMed - indexed for MEDLINE]
14.

The JAK2 V617F mutation in patients with cerebral venous thrombosis.

Passamonti SM, Biguzzi E, Cazzola M, Franchi F, Gianniello F, Bucciarelli P, Pietra D, Mannucci PM, Martinelli I.

J Thromb Haemost. 2012 Jun;10(6):998-1003. doi: 10.1111/j.1538-7836.2012.04719.x.

PMID:
22469236
[PubMed - indexed for MEDLINE]
15.

Prevalence of Janus Kinase 2 mutations in patients with unusual site venous thrombosis.

Basquiera AL, Tabares AH, Soria N, Salguero M, Ryser R, García JJ.

Medicina (B Aires). 2011;71(4):313-6.

PMID:
21893442
[PubMed - indexed for MEDLINE]
16.

Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.

Deepak A, Punamiya S, Patel N, Parekh S, Mehta S, Shah N.

Trop Gastroenterol. 2011 Oct-Dec;32(4):279-84.

PMID:
22696908
[PubMed - indexed for MEDLINE]
Free Article
17.

A sensitive and reliable semi-quantitative real-time PCR assay to detect JAK2 V617F in blood.

Poodt J, Fijnheer R, Walsh IB, Hermans MH.

Hematol Oncol. 2006 Dec;24(4):227-33.

PMID:
17006961
[PubMed - indexed for MEDLINE]
18.

JAK2 mutations across a spectrum of venous thrombosis cases.

Shetty S, Kulkarni B, Pai N, Mukundan P, Kasatkar P, Ghosh K.

Am J Clin Pathol. 2010 Jul;134(1):82-5. doi: 10.1309/AJCP7VO4HAIZYATP.

PMID:
20551270
[PubMed - indexed for MEDLINE]
Free Article
19.

A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC.

N Engl J Med. 2005 Apr 28;352(17):1779-90.

PMID:
15858187
[PubMed - indexed for MEDLINE]
Free Article
20.

Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.

P'ng S, Carnley B, Baker R, Kontorinis N, Cheng W.

Clin Gastroenterol Hepatol. 2008 Apr;6(4):472-5. doi: 10.1016/j.cgh.2007.12.046. Epub 2008 Mar 7.

PMID:
18328792
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk